六君子汤合二陈汤加减对冠心病患者Hcy,NO,hs-CRP的影响  

Effect of Modified Liu Junzitang and Erchentang on Hcy,NO,hs-CRP in Patients with Coronary Heart Disease

作　　者：胡芳 沈金峰 刘中勇[3] HU Fang;SHEN Jin-feng;LIU Zhong-yong(Jiangxi University of Traditional Chinese Medicine(TCM),Nanchang 330006,China;Wen ling First People's Hospital,Wen ling 317500,China;Affiliated Hospital of Jiangxi University of TCM、Nanchang 330006,China)

机构地区：[1]江西中医药大学,南昌330006 [2]温岭市第一人民医院,浙江温岭317500 [3]江西中医药大学附属医院,南昌330006

出　　处：《中国实验方剂学杂志》2020年第18期24-29,共6页Chinese Journal of Experimental Traditional Medical Formulae

基　　金：国家自然科学基金项目(81660781)。

摘　　要：目的:通过观察血清同型半胱氨酸(homocysteine,Hcy),一氧化氮(nitric oxide,NO),高敏-C反应蛋白(highsensitivity C-reactive protein,hs-CRP)与冠脉病变数量及程度的关系及其运用六君子汤联合二陈汤加减对冠心病(coronary heart disease,CHD)患者Hcy,NO,hs-CRP的影响,探讨六君子汤联合二陈汤加减对CHD患者的保护作用。方法:选取来自江西中医药大学附属医院2016年11月至2019年4月心血管科住院CHD(痰浊内阻型)患者76例,分析Hcy,NO,hs-CRP与冠脉病变数量及程度的关系。以抽签方式,将76例患者随机分为观察组和对照组,每组各38例患者。对照组患者给予常规治疗,观察组患者在常规治疗基础上服用六君子汤合二陈汤加减,周期为3个月。评估两组服药前后中医症状评分;检测两组患者服药前后Hcy,NO,hs-CRP,甘油三酯(TG),低密度脂蛋白(LDL),高密度脂蛋白(HDL),总胆固醇(TC),载脂蛋白A1(Apo A1),载脂蛋白B(Apo B),N末端B型利钠肽原(NT-proBNP),左心室射血分数(LVEF)指标。结果:Hcy,hs-CRP水平与冠脉病变支数及程度呈正相关。NO水平与冠脉病变支数及程度负相关关系。与本组治疗前比较,两组患者治疗后中医症状评分均有不同程度下降(P<0.05);与对照组治疗后比较,观察组在降低中医症状评分更明显(P<0.05)。与本组治疗前比较,两组治疗后可以降低Hcy,hs-CRP水平,提高NO水平(P<0.05);与对照组治疗后比较,观察组降低Hcy,hs-CRP水平及提高NO水平更明显(P<0.05)。与本组治疗前比较,两组治疗后均降低TG,LDL,TC,Apo A1,Apo B水平,提高HDL水平(P<0.05);与对照组治疗后比较,观察组可降低TG,LDL,TC,Apo A1,Apo B水平,提高HDL水平(P<0.05)。与本组治疗前比较,两组治疗后均可提高LVEF水平,降低NT-proBNP水平(P<0.05);与对照组治疗后比较,观察组可提高LVEF水平,降低NT-proBNP水平(P<0.05)。结论:Hcy,hs-CRP水平与冠脉病变呈正相关关系,NO水平与冠脉病变呈负相关,六君子�Objective:To observe the relationship between serum homocysteine(Hcy),nitric oxide(NO),high-sensitivity C-reactive protein(hs-CRP)as well as the number and degree of coronary lesions,and the effect of Liu Junzitang combined with Erchentang on Hcy,NO,hs-CRP in patients with coronary heart disease(CHD),so as to explore the protector effect of Liu Junzitang combined with Erchentang on CHD patients.Method:A total of 76 inpatients with phlegm turbidity and internal resistance(CHD)from the Cardiovascular Department of Jiangxi University of Traditional Chinese Medicine(TCM)from November 2016 to April 2019 were selected to analyze the relationship between Hcy,NO,hs-CRP as well as the number and degree of coronary lesions.By lottery,the 76 patients were randomly divided into observation group and control group,with 38 patients in each group.Patients in the control group were given conventional therapy,while patients in the observation group were given Liu Junzitang combined with Erchentang in addition to conventional therapy.The experimental period was 3 months.TCM symptom scores of the two groups before and after administration were evaluated.Hcy,NO,hs-CRP,triglyceride(TG),low-density lipoprotein(LDL),highdensity lipoprotein(HDL),and total cholesterol(TC),apolipoprotein A1(Apo A1),apolipoprotein B(Apo B),N-terminal B-type natriuretic peptide(NT-proBNP),left ventricular ejection fraction(LVEF)indicators of the two groups were measured before and after administration.Result:The levels of Hcy and hsCRP were positively correlated with the number and degree of coronary lesions.The level of NO was negatively correlated with the number and degree of coronary lesions.TCM symptom scores were different between the two groups after treatment.Compared with the control group,the TCM symptom score in the observation group was decreased more significantly(P<0.05).The two groups could reduce Hcy,hs-CRP and increase in NO to a certain extent(P<0.05).Compared with the control group,the observation group showed reduction in Hcy,hsCRP and i

关 键 词：六君子汤 二陈汤 冠心病 同型半胱氨酸(Hcy) 一氧化氮(NO) 高敏-C反应蛋白(hs-CRP) 

分 类 号：R22[医药卫生—中医基础理论] R242[医药卫生—中医学]